MCID: ADL048
MIFTS: 12

Adult Malignant Hemangiopericytoma

Categories: Cancer diseases, Rare diseases

Aliases & Classifications for Adult Malignant Hemangiopericytoma

MalaCards integrated aliases for Adult Malignant Hemangiopericytoma:

Name: Adult Malignant Hemangiopericytoma 12 74

Classifications:



External Ids:

Disease Ontology 12 DOID:6332
NCIt 51 C7946
UMLS 74 C0279547

Summaries for Adult Malignant Hemangiopericytoma

MalaCards based summary : Adult Malignant Hemangiopericytoma The drugs Mechlorethamine and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include brain and lung.

Related Diseases for Adult Malignant Hemangiopericytoma

Diseases in the Hemangiopericytoma, Malignant family:

Adult Malignant Hemangiopericytoma

Symptoms & Phenotypes for Adult Malignant Hemangiopericytoma

Drugs & Therapeutics for Adult Malignant Hemangiopericytoma

Drugs for Adult Malignant Hemangiopericytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 47)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Mechlorethamine Approved, Investigational Phase 3,Phase 1 51-75-2 4033
2
Ifosfamide Approved Phase 3,Phase 1 3778-73-2 3690
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
4
Lenograstim Approved, Investigational Phase 3 135968-09-1
5
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
6
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
7 Alkylating Agents Phase 3,Phase 2,Phase 1
8 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
9 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
10 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
11 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
12
Isophosphamide mustard Phase 3,Phase 1 0
13
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
14
Bevacizumab Approved, Investigational Phase 2 216974-75-3
15
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
16
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
17
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
18
Gemcitabine Approved Phase 2 95058-81-4 60750
19
Vatalanib Investigational Phase 2 212141-54-3 151194
20 Soblidotin Investigational Phase 2 149606-27-9
21
Camptothecin Experimental Phase 2 7689-03-4
22 Exatecan Investigational Phase 2 171335-80-1
23 Immunologic Factors Phase 2
24 Angiogenesis Modulating Agents Phase 2
25 Antineoplastic Agents, Immunological Phase 2
26 Angiogenesis Inhibitors Phase 2
27 Immunoglobulins Phase 2,Phase 1
28 Antibodies Phase 2,Phase 1
29 Antibodies, Monoclonal Phase 2,Phase 1
30 Protein Kinase Inhibitors Phase 2,Phase 1
31 Immunosuppressive Agents Phase 2
32 Imatinib Mesylate Phase 1, Phase 2 220127-57-1 123596
33 topoisomerase I inhibitors Phase 2
34 Antineoplastic Agents, Phytogenic Phase 2
35 Anti-Infective Agents Phase 2
36 Antiviral Agents Phase 2
37 Antimetabolites, Antineoplastic Phase 2
38 Antimetabolites Phase 2
39
Celecoxib Approved, Investigational Phase 1 169590-42-5 2662
40 Antirheumatic Agents Phase 1
41 Anti-Inflammatory Agents Phase 1
42 Analgesics Phase 1
43 Peripheral Nervous System Agents Phase 1
44 Cyclooxygenase 2 Inhibitors Phase 1
45 Analgesics, Non-Narcotic Phase 1
46 Cyclooxygenase Inhibitors Phase 1
47 Anti-Inflammatory Agents, Non-Steroidal Phase 1

Interventional clinical trials:

(show all 24)
# Name Status NCT ID Phase Drugs
1 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Completed NCT00423618 Phase 3
3 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
4 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
5 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
6 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
7 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
8 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
9 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
10 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00348790 Phase 2 vatalanib
11 S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas Completed NCT00217620 Phase 2 sorafenib
12 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
13 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
14 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
15 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
16 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
17 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
18 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
19 Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Recruiting NCT01532687 Phase 2 Gemcitabine Hydrochloride;Pazopanib Hydrochloride
20 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
21 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
22 Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Completed NCT00720174 Phase 1 Doxorubicin Hydrochloride
23 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
24 Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX Unknown status NCT00900211

Search NIH Clinical Center for Adult Malignant Hemangiopericytoma

Genetic Tests for Adult Malignant Hemangiopericytoma

Anatomical Context for Adult Malignant Hemangiopericytoma

MalaCards organs/tissues related to Adult Malignant Hemangiopericytoma:

42
Brain, Lung

Publications for Adult Malignant Hemangiopericytoma

Variations for Adult Malignant Hemangiopericytoma

Expression for Adult Malignant Hemangiopericytoma

Search GEO for disease gene expression data for Adult Malignant Hemangiopericytoma.

Pathways for Adult Malignant Hemangiopericytoma

GO Terms for Adult Malignant Hemangiopericytoma

Sources for Adult Malignant Hemangiopericytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....